Abstract
Recently there has been a significant reappraisal of the role of PDA in the context of neonatal cardiopulmonary disease. This article reviews surgical intervention, pharmacologic treatment, and assessment of ductal patency in the neonate.
MeSH terms
-
Alprostadil / therapeutic use
-
Blood Circulation
-
Clinical Trials as Topic
-
Digoxin / therapeutic use
-
Ductus Arteriosus / physiopathology
-
Ductus Arteriosus / surgery
-
Ductus Arteriosus, Patent / diagnosis
-
Ductus Arteriosus, Patent / physiopathology*
-
Ductus Arteriosus, Patent / therapy
-
Heart Defects, Congenital / complications
-
Heart Defects, Congenital / physiopathology
-
Heart Function Tests
-
Humans
-
Indomethacin / therapeutic use
-
Infant, Newborn
-
Infant, Premature, Diseases / physiopathology*
-
Ligation
-
Persistent Fetal Circulation Syndrome
-
Prostaglandin Antagonists / therapeutic use
-
Random Allocation
-
Respiratory Distress Syndrome, Newborn / physiopathology
Substances
-
Prostaglandin Antagonists
-
Digoxin
-
Alprostadil
-
Indomethacin